Internal Medicine: Neoplasms of the GI Tract and Adnexa

Internal Medicine: Neoplasms of the GI Tract and Adnexa — Expert Guide

How it begins

Las neoplasias del tracto gastrointestinal (GI) y sus órganos anexos (hígado, páncreas, vesícula y vías biliares) constituyen una de las principales causas de mortalidad por cáncer a nivel mundial. En conjunto, representan aproximadamente el 26% de la incidencia global de cáncer y el 35% de la mortalidad oncológica , según datos de GLOBOCAN 2022.

What it covers

1. General Epidemiology
2. · Transversal Risk Factors
3. Esophageal Neoplasms
4. · Epidermoid (Squamous) Carcinoma of the Esophagus
5. · Adenocarcinoma of the Esophagus and Barrett's Esophagus
6. · TNM Staging and Treatment
7. Gastric Neoplasms
8. · Gastric Adenocarcinoma
9. · H. pylori and the Correa Sequence
10. · Histological Classification
11. · Gastric MALT Lymphoma
12. · Gastric GIST
13. Small Intestine Neoplasms
14. Colorectal Neoplasms
15. · Colonic Polyps: Classification and Risk
16. · Adenoma → Carcinoma Sequence: Molecular Pathways
17. · Colorectal Adenocarcinoma: Clinical-Pathological Characteristics
18. · Hereditary Colorectal Syndromes
19. Pancreatic Neoplasms
20. · Pancreatic Ductal Adenocarcinoma (PDAC)
21. · Cystic Tumors of the Pancreas
22. · Pancreatic Neuroendocrine Tumors (pNET)
23. Primary and Metastatic Liver Neoplasms
24. · Hepatocellular Carcinoma (HCC / HCC)
25. · Cholangiocarcinoma
26. · Liver Metastases
27. Gallbladder and Biliary Tract Neoplasms
28. · Gallbladder Carcinoma
29. · Perihilar cholangiocarcinoma (Klatskin tumor)
30. Gastrointestinal Neuroendocrine Tumors (GI-NET)
31. · Classification, Histology and Gradation
32. · Functional Syndromes of NETs
33. Gastrointestinal Stromal Tumors (GIST): Global Overview
34. Hereditary Syndromes: Integrated Perspective
35. Diagnosis and Tumor Markers in Digestive Oncology
36. Modern Systemic Oncology in Digestive Tumors
37. · Immunotherapy: Checkpoint Inhibitors in GI Tumors
38. · Antibodies and Antibody-Drug Conjugates (ADC) in GI